Showing results (1921-1930 of 5,608) with videos related to
Sort By:
Pageof 561
Human Immunology|October 27, 2018
Allele diversity of the killer cell immunoglobulin-like receptors KIR3DL1/S1 and the combination with their HLA ligands in Mexican Mestizos from Mexico CityB A González-Quezada, M G J Sánchez-Fernández, A J Munguía-Saldaña, et al.Human Immunology|July 28, 2019
Genetic diversity of HLA system in two populations from Tabasco, Mexico: Villahermosa and rural TabascoRaúl Solís-Martínez, Rodrigo Barquera, Komathi Sree Ponnandai-Shanmugavel, et al.Human Immunology|July 22, 2019
CD56brightCD16- natural killer cells are shifted toward an IFN-γ-promoting phenotype with reduced regulatory capacity in osteoarthritisHuaqing Wang, Yong Zeng, Minghui Zhang, et al.Human Immunology|March 11, 2014
Vascular endothelial growth factor gene polymorphisms and vasculitis susceptibility: A meta-analysisGwan Gyu Song, Jae-Hoon Kim, Young Ho LeeHuman Immunology|March 11, 2014
Risk factors of sensitization to human leukocyte antigen in end-stage renal disease patientsShih-Yuan Hung, Tsun-Mei Lin, Min-Yu Chang, et al.Human Immunology|September 1, 1988
Epitope recognition by a DP alpha chain-specific monoclonal antibody (DP11.1) is influenced by the interaction between the DP alpha chain and its polymorphic DP beta chain partnerJ A Young, J Lindsay, J G Bodmer, et al.Human Immunology|August 1, 1989
HLA-DQw3-related determinants: analysis of subunit and spatial relationshipsS F Radka, K A Nelson, J V JohnstonHuman Immunology|April 24, 2014
Killer cell immunoglobulin-like receptors in Thai patients with leukemia and diffuse large B-cell lymphomaSasijit Vejbaesya, Pradermchai Sae-Tam, Archrob Khuhapinant, et al.Human Immunology|April 24, 2014
Early acute antibody-mediated rejection of a negative flow crossmatch 3rd kidney transplant with exclusive disparity at HLA-DPBeata Mierzejewska, Paul M Schroder, Caitlin E Baum, et al.Human Immunology|October 10, 2009
Co-engagement of alpha(4)beta(1) integrin (VLA-4) and CD4 or CD8 is necessary to induce maximal Erk1/2 phosphorylation and cytokine production in human T cellsTae Kon Kim, Matthew J Billard, Eric D Wieder, et al.Pageof 561